Articles tagged with Antibiotics
A team of researchers at the University of Illinois has successfully synthesized an antibiotic called fosfomycin in a non-native host, paving the way for new treatments against bacterial infections. The development is significant as it addresses the rising threat of antibiotic resistance.
A study published in Archives of Surgery found that a single dose of antibiotics prior to surgery is as effective as a 24-hour dosing regimen in preventing surgical site infections. The new protocol resulted in significant cost savings, with a 63% decline in antibiotic costs and a monthly saving of $1,980.
Researchers at Virginia Commonwealth University conclude that antibiotics are not effective in treating short-term bronchitis, which is usually caused by viral infections. The study suggests that physicians should inform patients that there is no data to support the use of antibiotics for this condition, saving them from potential side...
Scientists have discovered that the Chlamydia bacterium shares a common ancestry with plants, which could lead to the development of an effective new treatment for chlamydia. The discovery highlights similarities in genetic sequences and functions between the two organisms, providing a potential target for antibiotics.
A study found that 92% of ear infection cases were caused by bacteria, while 70% were caused by viruses. Viruses can impair antibiotic efficacy, leading to partial effectiveness in treating AOM.
Researchers at Ohio State University have developed a new method to create polymer rings that can encapsulate and release specific molecules at specific times. The technique has the potential to be used in medicine, particularly in drug delivery and antibiotic development.
Researchers are using bacteria to manufacture a library of potential anti-cancer drugs, including analogues of streptorubin B, which could be more powerful than current synthetic options. The approach combines biology and organic synthesis to create complex structures.
Researchers at the University of Illinois have discovered a new two-component lantibiotic called haloduracin, which has shown promising therapeutic potential in treating nasty infections. The discovery could provide new sources of antibiotics to combat drug-resistant bacterial strains.
For most children with middle ear infection, an observation policy is justified due to limited benefits from antibiotics. The study found that only some children under the age of two benefit from antibiotic treatment, while others may require more treatments to prevent extended disease cases.
A new study suggests that rifaximin may improve IBS symptoms by over 50% compared to placebo. However, the researchers caution that antibiotics can have side effects and more research is needed to fully understand its benefits.
Researchers at Cedars-Sinai Medical Center found that a nonabsorbable antibiotic can effectively treat irritable bowel syndrome (IBS) even after treatment ends. The study showed sustained benefits for participants who received rifaximin, providing new hope for those suffering from IBS.
A new study found that patients with irritable bowel syndrome (IBS) reported greater global improvements in symptoms and less bloating after taking rifaximin, an antibiotic. The randomized, double-blind study demonstrated a sustained benefit of an antibiotic for IBS symptoms even after treatment was stopped.
Researchers have successfully synthesized platensimycin, a new antibiotic that inhibits bacterial fatty acid biosynthesis and paralyzes Gram-positive bacterial strains. This breakthrough offers hope against multiresistant bacteria, including Staphylococcus aureus and Enterococcus faecium.
A study by Indiana University researchers found that hospitals implementing specific measures to control antibiotic use were more likely to succeed in controlling antibiotic resistance. Measures such as limiting broad-spectrum drug availability and restricting formularies were associated with lower rates of antibiotic resistance.
The Infectious Diseases Society of America has updated its Clinical Practice Guidelines for the diagnosis and treatment of Lyme disease. The new guidelines include recommendations for a single dose of antibiotic for high-risk patients and expanded discussion on chronic post-Lyme syndromes.
Researchers at the University of Illinois Chicago have identified an antibiotic that specifically targets the FoxM1 gene, which is responsible for cancer cell proliferation. The antibiotic, siomycin A, was found to induce cancer cells to commit suicide in a process called apoptosis, with no effect on normal cells.
A study in Vietnam found that targeted oral azithromycin treatment increased re-infection rates of trachoma and Chlamydia trachomatis infection. The SAFE strategy, which includes antibiotics, has been criticized for its potential ineffectiveness in long-term control.
A recent study found a possible link between the use of proton pump inhibitors and an increased risk of community-acquired Clostridium difficile-associated disease. The research, published in the Canadian Medical Association Journal, suggests that patients who have been prescribed these medications may be more likely to develop CDAD.
A new study found that giving parents a 'wait-and-see' approach for treating ear infections significantly reduced the use of antibiotics, with little difference in outcomes for the children. The approach also interrupted the cycle of antibiotic prescription, reducing adverse effects and costs.
Researchers have discovered a new approach to develop antibiotics, which is more efficient and environmentally friendly. This breakthrough could help create powerful new drugs to combat the growing threat of antibiotic resistance.
A team of Wisconsin scientists has found a simple process to expand on nature's chemical creativity, making critical anticancer agents and antibiotics. The discovery opens the door to a variety of new opportunities in the natural product drug arena.
Researchers developed an inhibitor that blocks anthrax toxin receptors, increasing potency by 50,000-fold. The new approach could combat antibiotic-resistant strains and improve survival rates for inhalational anthrax victims.
Scientists at the University of York have discovered a critical element in the mode of action of DNase colicins, which kill cells by destroying their DNA. Understanding this mechanism could lead to the development of new, targeted antibiotics.
A Purdue University researcher has determined the structure of a protein that controls starvation response in E. coli, which can be targeted to combat bacterial infections. The protein is found in numerous harmful bacteria and is an excellent antibiotic target due to its high processivity.
Researchers at St. Jude Children's Research Hospital used computer-generated images of enzyme pantothenate kinase to unlock mysteries of antibiotic resistance and rare brain degeneration. The study found that despite differences in enzyme structure, types II and III can perform the same job as type I, leading to antibiotic resistance.
MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country, according to a UCLA study. The infection was found to be resistant to commonly used antibiotics, emphasizing the need for clinicians to culture infections and prescribe effective medications.
A trachoma control programme using the SAFE strategy, which combines surgery, antibiotics, facial cleanliness, and environmental change, significantly reduced active trachoma prevalence by 92% in two districts. The study highlights the potential for this approach to also benefit other communicable diseases like diarrhoea and pneumonia.
A new tooth whitening procedure developed by Dr. Kim L. Capehart has been found to significantly lighten stubborn tetracycline stains, saving patients over $10,000 in dental restorative fees. The treatment involves a combination of prescription fluoride toothpaste, UV light, and customized trays.
The launch of Tygacil (tigecycline) in the UK marks a significant step forward in the fight against antibiotic-resistant bacteria, including MRSA and Escherichia Coli. The new antibiotic has been developed to overcome common mechanisms of resistance and offers a single effective therapy for complicated skin and soft tissue infections.
Researchers found that pretreatment with rapamycin induces a protective effect against heart attack injury by maintaining ATP levels in heart cells. The study suggests that rapamycin may be beneficial as a potential therapeutic strategy to limit cell death and prevent long-term heart damage.
A biomarker named procalcitonin can reduce the length of antibiotic treatment for community-acquired pneumonia (CAP) patients. Studies found that lower procalcitonin levels could shorten antibiotic use by an average of seven days, but guidelines suggest shorter courses and caution against over-reliance on this marker.
A study published in the Journal of the Royal Society of Medicine found that reducing antibiotic prescribing was associated with an increase in hospital admissions for respiratory infections. The research analyzed data from over 15 million hospitalizations and suggested that limiting antibiotic use may not be beneficial in all cases.
The overuse of antibiotics in fish farming can lead to increased bacterial resistance and disease risk. Consuming contaminated fish products can transfer these resistant bacteria to humans, posing a significant health threat.
Researchers discovered that an endogenous peptide called LL-37 plays a critical role in preventing urinary tract infections. Boosting LL-37 levels may provide a new way to prevent UTIs and offer a defense against the infection.
Research reveals that non-pathogenic bacteria from cow manure share antibiotic-resistance genes with multi-drug resistant Salmonella strains on the same farm. Ecology appears to play a major role in the spread of drug resistance, rather than therapeutic antibiotic use.
A new treatment using fosfomycin has shown promise in treating Listeria infections, which cause severe food-borne diseases. The drug was ineffective in laboratory tests but proved effective in the body, highlighting the need to revise testing methods.
Researchers found that a vaccine combined with short-term antibiotic treatment can protect nonhuman primates from inhalational anthrax. The study suggests that this combination may be crucial for successful defense against large-scale anthrax attacks, minimizing the risk of adverse events and improving public health management.
Researchers found that aspirin significantly reduces the risk of hearing loss when paired with gentamicin, a commonly used antibiotic. The study, conducted in China and published in the New England Journal of Medicine, showed a 75% lower incidence of hearing loss in patients given aspirin compared to those receiving placebos.
A study examining Campylobacter jejuni isolates from 585 Australian patients found only 2% were resistant to ciprofloxacin, a type of fluoroquinolone. This low level of resistance likely reflects Australia's policy of prohibiting fluoroquinolones for animal use.
Telithromycin shows promise in treating acute asthma attacks, reducing symptoms and recovery time. The antibiotic's anti-inflammatory properties may also help alleviate severity of asthma attacks.
Researchers at UCSD have discovered how bacterial messenger RNA is unfolded to be read by the cell's protein-making machinery. The study reveals essential factors required for this process and provides insights into developing novel antibiotics targeting these vulnerabilities.
The Franz Edelman competition recognizes outstanding O.R.-based projects that have transformed companies, entire industries, and people's lives. The finalists applied O.R. techniques to address complex issues such as antibiotic use in animals, aviation security, and supply chain optimization.
The study found that antibiotics and synthetic hormones can increase antibiotic resistance and disrupt endocrine functions. Researchers identified key metabolites from commonly prescribed medications and hormone replacement therapy, highlighting the need for optimized wastewater treatment processes to remove these compounds.
A recent Johns Hopkins Medicine study found that a single dose of azithromycin significantly reduces the risk of trichiasis recurring for up to one year after lid surgery. The researchers compared azithromycin to six weeks of topical tetracycline treatment and found that azithromycin resulted in one-third fewer recurrences.
Researchers found PDT to be highly effective against drug-resistant bacteria and fungus, including S. mutans and Candida species, with minimal doses of light required to kill nearly all organisms.
Scientists successfully synthesized nisin, a peptide antibiotic, in a test tube using just two enzymes. The compound's unique structure and properties make it a potential candidate for developing new antibiotics with reduced resistance.
Researchers at the University of Michigan have developed a novel method to weaken Gram-negative bacteria, including E. coli, making them susceptible to existing antibiotics. The approach, which involves genetic modification, has shown promising results in reducing antibiotic doses needed to kill the bacteria.
A study found that a single mass antibiotic treatment does not prevent the return of eye infections in communities with high disease prevalence. Infection rates rose again after 2 years, highlighting the need for repeated treatments or other measures to eliminate infection.
A recent study indicates a significant increase in antibiotic-resistant community-acquired Staphylococcus aureus (MRSA) infections, affecting urban populations in the Atlanta area. The study reveals that 72% of community-onset skin and soft tissue infections are now due to MRSA USA300 strain.
The study found that timely antibiotic treatment was key to patients' survival, with a mortality rate of nearly 80% when treatment was delayed beyond six days. Anthrax progression to its advanced stage often leads to certain death, even with modern care.
Researchers successfully synthesized a novel vancomycin analogue with enhanced binding ability, showing promise in treating vancomycin-resistant infections. The new compound could potentially lead to the development of more effective antibiotics against these resistant strains.
Researchers genetically engineered E. coli to lack its outer protective layer, making it more vulnerable to antibiotics. Synthetic versions of natural substrates for gram-positive bacteria's membrane formation are also being developed, potentially leading to new antibiotic designs.
A study led by Dr. Antonio Anzueto found that the newer medication moxifloxacin HCI is more effective at treating community-acquired pneumonia (CAP) in elderly patients, with a recovery rate of 97.9%, compared to 90% for the standard medication levofloxacin. The study also assessed cardiac safety and found both treatments to be safe.
Researchers report three cases of severe liver failure and hepatitis linked to telithromycin, a newly approved antibiotic. The study highlights the potential risk of idiosyncratic drug reactions at one medical center.
Researchers screened 480 strains of soil bacteria for resistance to 21 antibiotics and found that all were multi-drug resistant. The study suggests that studying resistance in the soil can help predict future clinical problems and guide the development of new therapies.
Long-term antibiotic medication does not prevent recurrent myocardial infarcts in patients without periodontitis. Patients with periodontitis are more likely to experience cardiovascular events, especially under the age of 65.
A study found that current use of proton pump inhibitors was associated with nearly 3 times the rate of CDAD; use of H2-receptor antagonists was associated with twice the rate of CDAD. The rates and severity of nosocomial CDAD are increasing, posing a significant public health concern.
A recent study published at the American College of Gastroenterology's annual meeting found that targeted antibiotics, specifically rifaximin, resulted in a significant and long-lasting improvement in IBS symptoms. Patients who received the antibiotic experienced a 37% overall improvement in their symptoms, compared to 23% on placebo.
Scientists have captured high-resolution snapshots of the bacterial ribosome, allowing them to build more detailed models and gain insights into how specific antibiotics work. The new data reveals the ribosome's structure and function during protein manufacturing, including its ability to withstand stress and neutralize negative charge.
Researchers have discovered additional sites on ribosomes that could be targeted by antibiotics to combat bacterial resistance. The study provides new potential targets for pharmaceutical companies to create novel antibiotics, keeping pace with the evolving threat of antibiotic resistance.